Fast Products Of New Hope for Gynecologic Cancer For 2012
Posted by admin | Uncategorized | Posted on January 22nd, 2012
Victims that have gynecologic cancer have all new hope with a creative technology currently introduced at the Seidman Cancer Center at University Hospitals Case Medical Center. A team of cancer specialists, led by Robert DeBernardo, MD, is among the first in the nation to launch a dedicated program using Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat ovarian, endometrial and select other cancers.
Implemented asap following surgical procedure, HIPEC brings heated chemotherapy through a ‘hot bath’ into the abdominal cavity, where it can penetrate diseased tissue directly. Subsequently after the doctor removes the maximum visible cancer as attainable, a heated, a sterilized chemotherapy solution is distributed around the abdomen by using a technically advanced perfusion technique to kill the surviving cancer cells.
“This is a new and potentially revolutionary way of treating women with gynecologic cancers, which tend to be quite responsive to chemotherapy,” says Dr. DeBernardo, gynecologic oncologist at UH Case Medical Center and Assistant Professor at Case Western Reserve University School of Medicine. “Our preliminary data and experience has been overwhelmingly positive and the therapy has been well-tolerated and effective. HIPEC promises to extend lives in a meaningful way.”
HIPEC has been used for years for public health care in patients with colon, pseudomyxomas, malignant mesothelioma and appendiceal cancer, cancers that typically are usually not receptive to chemotherapy, however it’s currently viewed as an encouraging brand new treatment for gynecologic malignancy.